U.S. markets closed

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
244.68-0.40 (-0.16%)
At close: 4:00PM EDT
243.80 -0.88 (-0.36%)
After hours: 07:10PM EDT
Sign in to post a message.
  • k
    keith
    AMGN is overdue for a move up. It hasn't done jack for over a year.
  • W
    Weyrtuyww
    this stock is like a bond....dependable 3% yield but not a chance of capital gain
  • K
    KeethD
    Soon the bad news is coming for AMGN

    Mirati Therapeutics Inc (NASDAQ:MRTX): Mirati's KRAS inhibitor adagrasib has a Phase 2 readout in second-line and above non-small cell lung cancer settings in the second half, Gerberry said in the note. This readout offers more apples-to-apples comparison with Amgen, Inc.'s (NASDAQ:AMGN) sotorasib, which has already been approved, he added.
  • l
    lizbet
    I bought into Amgen many years ago, this is a great company with a great pipeline. read their bio
  • J
    Jim
    This has traded sideways for about a year now it’s ready to move up
  • J
    Jim
    6 years in and up $100 per share!!
  • l
    leslein
    I don’t know what I would do without the help of (http://Thetraderguide.com). Their watchlists are so well researched and help me make the best possible picks when it comes to investing. Not only do they save me time, but their advice has shown to be tried and true!
  • J
    John
    I will lighten up on AMGN it was a good value at .34 cents and I missed it. I read the announcements and wanted to be part of this great company but its not going to 1000 from here. I am late to the party and can't turn back the hands of time the float is too big for the growth I need .
  • T
    Tad
    $ARWR conversation
    amgn just won approval for kras blocking lung cancer drug....
    from twitter: "You have to give $AMGN credit here...moved at lightning speed, AMG 510 only began enrolling for P1 in July of 2018"
    lets put hif2 on a similar timeline/path
  • v
    vic
    Finally! It builds support and up it goes from here!
    We got lung cancer approved by FDA, and I can’t wait for FDA to approve the 2nd one!

    This will easily hits $300 by EOY, and not to mention great Divi!
  • J
    John
    To make any real money for me with my small position AMGN would need to reach $1000. When Mgt was asked about competition at most recent presentation " we love our molecule " was the answer. Mgt also made impressive statements about how they are ready to rock an roll with getting the pill to patients fastest with the mostest.
  • s
    stocktargetadvisor
    $AMGN
    Target Raised by SVB Leerink Market Perform USD 230 » USD 238
    Target Raised by Oppenheimer Holdings Outperform USD 272 » USD 277
    www.stocktargetadvisor.com/stock/USA/NSD/AMGN#analyst-rating-tab
  • S
    Saint Preferred
    All the children knocking AMGN. Go play with GME and COIN, its more your speed.
  • l
    lizbet
    buy Amgen
  • a
    art
    Short interest increasing, below 50 & 200 day moving average! Luv the dividend but going to be on sidelines till bottoming process complete! GLTL!
    Neutral
  • J
    John
    stukinstukin13 hours ago
    I predict that the most recent "approval" will be far less valuable than most people expect in the long-run. The race to move quickly tells the whole story. Urgency was the main objective given the fact that this drug will very likely be supplanted by a newer generation drug long before the current one is fully monetized. The press releases paint a far less rosy picture than what most shareholders are expecting. The most troubling indicator has been the severe weakness since right before the announcement came public. The inside money clearly knew, in advance, that there were some big caveats to the supposedly good news. I strongly suspect that the company was buying on Friday of last week in an effort to mitigate the damage to the share price. The picture that I see unfolding is not a pretty one for AMGN shareholders. Stay tuned. The story is far from over. We could easily see AMGN below $200 in short order.
  • v
    vic
    Glad I Dumped all my shares yesterday at the peak, this #$%$ is not going anywhere!
  • l
    lizbet
    you hammer on the stock, but if you had to rely on a stock that would payout to support your kids college tuition, what stock are you choosing that has what Amgen has
  • J
    John
    nothing less than huge increase in earning will make any difference to AMGN followed by higher divi. maybe they should reheadquarter to Austin or Florida
  • J
    John
    well international affairs dominates early this week but the administration must come home and be accountable for the countries economic realities. Vagas odds on Putin giving him that Coyote grin for the paper road runner